Le Dr Agnes Binagwaho, pédiatre de formation et ministre de la Santé du Rwanda, est la deuxième personnalité à remporter le prix Roux, une récompense de 100 000 USD pour avoir utiliser des faits établis dans le cadre de l’amélioration de la santé. C’est le plus important prix de ce genre au niveau international. Le Dr Binagwaho a utilisé les données du Global Burden of Disease (GBD, charge mondiale de morbidité) et les résultats recueillis grâce aux efforts de son propre ministère pour s’assurer que les ressources limitées du pays sauvent le plus de vies possible et diminuent les souffrances de la population.
Dr. Agnes Binagwaho, a trained pediatrician and Minister of Health of Rwanda, is the second winner of the Roux Prize, a US$100,000 award for turning evidence into health impact and the largest prize of its kind. Dr. Binagwaho has been using Global Burden of Disease (GBD) data and evidence from the Ministry’s own data-gathering efforts to ensure the country’s limited resources are saving the most lives and reducing suffering.
Collaborators and the GBD study
As a Collaborator, you will have many opportunities to participate in the GBD study in diverse ways. You can suggest new data sources, critique results, give feedback on covariates and modeling approaches, contribute to publications, participate as co-aut...
The University of Washington Press has published An Integrative Metaregression Framework for Descriptive Epidemiology, an in-depth explanation of the methods underlying the morbidity estimation in the Global Burden of Disease (GBD) study.
UK Prime Minister Theresa May’s new NHS Long Term Plan, a 10-year blueprint for health services, relies substantially on the Global Burden of Disease (GBD) study to frame priorities for tackling premature death and disability.
These two-page summaries offer a concise overview of risk factors modeled in GBD and the health loss attributable to them. The summaries feature a summary results statement, a definition of the risk, and a brief listing of modeling updates in GBD 2019 compared t...
British people spend more time with chronic illness and disability than most Europeans. Young adults are hit hard by alcohol and drug use.
In Sweden, the Department of Public Health Sciences, Karolinska Institute, and the Center for Epidemiology and Community Medicine (CES) collaborated with IHME to develop estimates for the burden of disease in Stockholm County. These are now a key feature of the county’s Public Health Guide, which serves as a valuable reference for Stockholm’s government and civil society as they work to promote health and prevent disease.
This study’s objective is to describe unintentional drowning using GBD estimates from 1990 to 2017.
Through the Global Burden of Diseases, Injuries, and Risk Factors (GBD) studies, headache has emerged as a major global public health concern. We aimed to use data from the GBD 2016 study to provide new estimates for prevalence and years of life lived with disability (YLDs) for migraine and tension-type headache and to present the methods and results in an accessible way for clinicians and researchers of headache disorders.
This study used the estimates of the GBD to summarise the state of health in Spain in 2016 and report trends in mortality and morbidity from 1990 to 2016.
Two investigators independently assessed 15 skin conditions studied by GBD 2010 in the NIAMS database for grants issued in 2013. The 15 skin diseases were matched to their respective DALYs from GBD 2010.
Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013), we estimated these quantities for acute and chronic diseases and injuries for 188 countries between 1990 and 2013.
Up-to-date evidence on levels and trends for age-sex-specific all-cause and cause-specific mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990 and 2013. We used the results to assess whether there is epidemiological convergence across countries.
Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and program decision-making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: disability-adjusted life years (DALYs) and healthy life expectancy (HALE). We used these measures to track trends and benchmark progress compared with expected trends on the basis of the Socio-demographic Index (SDI).
In 2012, data from GBD 2010 were published, providing results for 1990, 2005, and 2010. Hundreds of collaborators reported summary results for the world and 21 epidemiologic regions, covering 291 diseases and injuries, 1,160 sequelae of these causes, and mortality and burden attributable to 67 risk factors. GBD 2010 addressed a number of major limitations to previous analyses, including strengthening the statistical methods used for estimation and using disability weights derived from surveys of the general population. Metrics produced include leading causes of death, years of life lost, years lived with disability, and disability-adjusted life years (DALYs), which are the years of healthy life lost by a person due to death or disability.
The Global Burden of Diseases (GBD) 2017 database permits an up-to-date evaluation of the frequency and burden of diabetes at the state level in Brazil and by type of diabetes. The objective of this report is to describe, using these updated GBD data, the current and projected future burden of diabetes and hyperglycemia in Brazil, as well as its variation over time and space.
In Mexico, evidence from the Global Burden of Disease study plays a central role in guiding health policy. As Secretary of Health of Mexico from 2000 to 2006, Dr. Julio Frenk was the first leader in the country to use Global Burden of Disease (GBD) findings to guide health policy. Burden of Disease research helped shape the package of health services provided to all Mexicans.
Established in 2000, Millennium Development Goal 4 (MDG4) catalyzed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 Study (GBD 2015) provides an analytical framework to comprehensively assess these trends for under-5 mortality, age-specific and cause-specific mortality among children under 5 years, and stillbirths by geography over time.
Understanding how prevalence, incidence, and mortality of motor neuron diseases change over time and by location is crucial for understanding the causes of these disorders and for health care planning. Our aim was to produce estimates of incidence, prevalence, and disability-adjusted life years (DALYs) for motor neuron diseases for 195 countries and territories from 1990 to 2016 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016.